DHG Pharmaceutical JSC
DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, and dermatology and beauty care products. It also manufactures a… Read more
DHG Pharmaceutical JSC - Asset Resilience Ratio
DHG Pharmaceutical JSC (DHG) has an Asset Resilience Ratio of 39.18% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2025)
This chart shows how DHG Pharmaceutical JSC's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down DHG Pharmaceutical JSC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₫0.00 | 0% |
| Short-term Investments | ₫2.02 Trillion | 39.18% |
| Total Liquid Assets | ₫2.02 Trillion | 39.18% |
Asset Resilience Insights
- Very High Liquidity: DHG Pharmaceutical JSC maintains exceptional liquid asset reserves at 39.18% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
DHG Pharmaceutical JSC Industry Peers by Asset Resilience Ratio
Compare DHG Pharmaceutical JSC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Biostar Pharmaceuticals Inc
PINK:BSPM |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
High Sierra Technologies Inc
PINK:HSTI |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423 |
Drug Manufacturers - Specialty & Generic | 20.44% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
Annual Asset Resilience Ratio for DHG Pharmaceutical JSC (2019–2025)
The table below shows the annual Asset Resilience Ratio data for DHG Pharmaceutical JSC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 39.18% | ₫2.02 Trillion | ₫5.17 Trillion | -6.88pp |
| 2024-12-31 | 46.06% | ₫2.75 Trillion | ₫5.96 Trillion | +9.57pp |
| 2023-12-31 | 36.49% | ₫2.23 Trillion | ₫6.11 Trillion | -9.07pp |
| 2022-12-31 | 45.57% | ₫2.35 Trillion | ₫5.17 Trillion | -0.13pp |
| 2021-12-31 | 45.69% | ₫2.11 Trillion | ₫4.62 Trillion | -0.94pp |
| 2020-12-31 | 46.63% | ₫2.07 Trillion | ₫4.45 Trillion | +4.00pp |
| 2019-12-31 | 42.64% | ₫1.77 Trillion | ₫4.15 Trillion | -- |